Gordon Cummins, MS

home / authors / gordon-cummins-ms

Articles

Site Logo
January 1st 2002

Use of Managed Care Claims Data in the Risk Assessment of Venous Thromboembolism in Outpatients

Mason W. Russell, MAPE Douglas C. A. Taylor, MBA Gordon Cummins, MS Daniel M. Huse, MA

Site Logo
January 1st 2002

Outpatient Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin: An Economic Evaluation

Daniel M. Huse, MA Gordon Cummins, MS Douglas C. A. Taylor, MBA Mason W. Russell, MAPE

Site Logo
September 1st 2001

Comparison of Rheumatoid Arthritis Care Costs in Patients Starting Therapy with Leflunomide Versus Etanercept

Cyrus Yazdani, MS Trent McLaughlin, PhD Gordon Cummins, MS Joseph Doyle, RPh, MBA

Site Logo
May 1st 2001

Report: A Descriptive Analysis of the Use and Cost of New-Generation Antihistamines in the Treatment of Allergic Rhinitis: A Retrospective Database Analysis

Jeff Lee, PharmD Gordon Cummins, MS Lynn Okamoto, PharmD

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Hurricane | Image credit: Satoshi Kina - stock.adobe.com
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Aaron Gerds, MS, MS | Image credit: Cleveland Clinic
Published: October 11th 2024 | Updated: November 21st 2024
NCCN Guidelines for MPN Reflect New Drugs, Focus on Clinical Trials

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo